Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-07-14

FDA Approved: PROCHLORPERAZINE EDISYLATE — Original Application (Eugia US LLC)

View source ↗

Summary

FDA approves the original application for Prochlorperazine edisylate (generic) by Eugia US LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prochlorperazine edisylate (Prochlorperazine edisylate)

Snippet

ORIG AP for PROCHLORPERAZINE EDISYLATE (PROCHLORPERAZINE EDISYLATE)